A news study at the University of Pittsburgh School of Medicine has revealed that viruses might contribute to cancer by causing excessive death to normal cells while promoting the growth of surviving cells with cancerous traits.
Led by Preet M. Chaudhary, M.D., Ph.D., professor of medicine, the study has suggested that viruses may act as forces of natural selection by wiping out normal cells that support the replication of viruses and leaving behind those cells that have acquired defects in their circuitry. When this process is repeated over and over, cancer can develop.
Infection with viruses has been linked to many human cancers, including some forms of Hodgkin's and non-Hodgkin's lymphomas, sarcomas and cancers of the throat and liver. Over the years, scientists have proposed a number of mechanisms to explain this link. One commonly held belief is that when a virus infects a cell, its genetic material alters the cell, making it grow uncontrollably, eventually leading to cancer. Some viruses also are thought to promote cancer by causing chronic inflammation.
He named this model the Phoenix Paradigm in which cancer theoretically arises out of the ashes of dead cells. The paradigm was developed based on a study of cells infected with the Kaposi's sarcoma associated herpesvirus, or KSHV, also known as human herpesvirus 8 (HHV-8).
The research team examined a gene called K13 that activates a pathway previously implicated in cancer development. The researchers found that cells with low K13 expression allowed KSHV to replicate, and these cells subsequently died off. Cells with higher expression of K13 emerged after KSHV replication and showed defective expression of two key proteins that are known to promote cancer.
"This paradigm, if validated by further studies, has implications not only for an improved understanding of the processes involved in cancer, but also for the development of effective strategies for its prevention and treatment," Dr. Chaudhary said.
The study is published by Public Library of Science in the Oct. 24 issue of PLoS ONE.